Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2025
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-13-february-2025
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-13-february-2025
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2025
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-january-2025
https://www.ema.europa.eu/en/news/new-eu-rules-health-technology-assessments-become-effective
All of us here at Pharmya wish you a prosperous New Year. May 2025 bring health, success, and fruitful collaboration. Together, let’s continue working towards patient safety and progress in pharmacovigilance.
https://www.ema.europa.eu/en/news/common-eu-approach-data-transparency-medicine-regulation
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-25-28-november-2024